Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Microvascular Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Microvascular Therapeutics

Microvascular Therapeutics

MVT: A biotech firm innovating in ultrasound contrast, theranostics, and disease diagnosis.

HQ
Tucson, AZ, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Microvascular Therapeutics (MVT) is a biotechnology company founded with the mission to innovate in the fields of ultrasound contrast and theranostics. The company focuses on developing advanced microbubble and nanotechnology products aimed at improving the diagnosis and treatment of various diseases. One of their key products, MVT-100, is an ultrasound contrast agent with a neutral surface chemistry, designed to serve as a platform for molecular imaging and image-guided therapy. MVT targets the healthcare market, particularly in diagnostic imaging and therapeutic applications.

Notable figures associated with MVT include experts in biotechnology and medical imaging, although specific names are not provided. The company has received formal guidance from the FDA to develop MVT-100 via the 505(b)(2) regulatory pathway, marking a significant milestone. This achievement underscores MVT's potential impact on enhancing diagnostic accuracy and therapeutic efficacy in medical practice. Through its pioneering work, MVT aims to revolutionize the landscape of disease diagnosis and treatment, contributing to better patient outcomes.

Microvascular Therapeutics - Similar Companies

MicroVascular Tissues logo

MicroVascular Tissues

mvtissues.com

Mercator Medsystems logo

Mercator Medsystems

mercatormed.com

Micro Medical Solutions logo

Micro Medical Solutions

Precision Theranostics logo

Precision Theranostics

Micron Biomedical logo

Micron Biomedical

Microbiome Therapeutics logo

Microbiome Therapeutics

ThromboVision logo

ThromboVision

TheraVasc logo

TheraVasc

Mirabilis Medica logo

Mirabilis Medica

Vascular Therapies logo

Vascular Therapies

vasculartx.com

United Therapeutics logo

United Therapeutics

Mvrx logo

Mvrx

MicroElastic Ultrasound Systems logo

MicroElastic Ultrasound Systems

microelastic.com

Traverse Vascular logo

Traverse Vascular

Verasonics logo

Verasonics

verasonics.com

Microvascular Therapeutics - Quick Facts

Who are Microvascular Therapeutics' competitors?

Companies similar to Microvascular Therapeutics include MicroVascular Tissues, Mercator Medsystems, Micro Medical Solutions and Precision Theranostics.

When was Microvascular Therapeutics founded?

Microvascular Therapeutics was founded in 2016.

Where is Microvascular Therapeutics' headquarters located?

Microvascular Therapeutics' headquarters is located in Tucson, AZ, US.

When was Microvascular Therapeutics' last funding round?

Microvascular Therapeutics' most recent funding round was for $4M (USD) in October 2023.

How much has Microvascular Therapeutics raised to-date?

As of Oct 18, 2023, Microvascular Therapeutics has raised a total of $5.6M (USD).

How many employees does Microvascular Therapeutics have?

Microvascular Therapeutics has 5 employees as of Feb 4, 2024.

Microvascular Therapeutics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Theranostics
  • Ultrasound Contrast
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541500Computer Systems Design and Related Services
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 513210Software Publishers
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 8000Health Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7371Computer Programming Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified